• Aucun résultat trouvé

[PDF] Top 20 Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.

Has 10000 "Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort." found on our website. Below are the top 20 most common "Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.".

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.

... because the overall health risks exceeded the benefits. In particular, it showed an increased breast cancer risk in the CEE plus MPA ...recently, the Million ... Voir le document complet

13

Effect of physical activity on women at increased risk of breast cancer: results from the E3N cohort study.

Effect of physical activity on women at increased risk of breast cancer: results from the E3N cohort study.

... history of breast cancer in first-degree relatives (yes/no), age at menarche (cut points: 12, 13, and 14), age at first full-term pregnancy (cut points: 23, 26, and 30 years), parity (0, 1-3, ... Voir le document complet

11

Recent Recreational Physical Activity and Breast Cancer Risk in Postmenopausal Women in the E3N Cohort

Recent Recreational Physical Activity and Breast Cancer Risk in Postmenopausal Women in the E3N Cohort

... two types of physical activity. The decrease in risk observed with a 12 MET-h/week exercise level is consistent with the World Cancer Research Fund recommendations ... Voir le document complet

11

Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.

Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.

... -positive breast cancer with the menopause-related ces- sation of ovarian estrogen and/or progesterone synthesis ...array of epidemiologic, clinical and experimental evidence has ... Voir le document complet

15

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.

... analyses to women who had not been using HRT before the baseline questionnaire (‘‘incident ...analysis in this way in our previous study [16], to avoid potential biases described by Ray ... Voir le document complet

11

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

... now in their late 50s and early 60s were at the start of their contraceptive life when OCs became readily available in the ...had the possibility of using OCs at a young ... Voir le document complet

11

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

... important to realize that recent findings relating to the use of natural progesterone, in sharp contrast with those referring to the use of progestins, are ...two ... Voir le document complet

19

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.

... Methods The European Prospective Investigation into Cancer and Nutrition (EPIC) is a multi-center prospective cohort study designed to investigate the relationships between diet, ... Voir le document complet

13

Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort

Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort

... strength of our study lies on the regular updates of exposure, which limited classification bias and allowed to account for possible changes over time in the types ... Voir le document complet

24

Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.

Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.

... is the first to consider different types of MHT combinations on diabetes risk, several authors have reported the impact of different types of ... Voir le document complet

16

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

... Meta-analysis of observational studies showed that oral but not transdermal oestrogen increased the risk of venous ...interval) of first-time venous thromboembolism in current ... Voir le document complet

35

Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort.

Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort.

... lower risk of ER-/PR- breast cancer in women with serum levels of PCBs in the highest tertile compared to the lowest ...investigating breast ... Voir le document complet

11

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

... underlies the method of weighting used in our analyses is that the absolute disease risks are well estimated and ascertainment is not dependent on the covariates of interest ... Voir le document complet

32

Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

... polymorphisms in the genes that code for GNRH1 or its receptor and either cir- culating ovarian sex hormones or breast cancer ...influence of SNPs in these two genes on ... Voir le document complet

9

Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.

Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.

... that breast cancer risk decreases with increasing age at menarche ...that in our study the role of age at menarche was apparent only before adjustment for age at onset of ... Voir le document complet

9

Development of a multi-gene PCR assay for the prediction of the response to hormone therapy in breast cancer

Development of a multi-gene PCR assay for the prediction of the response to hormone therapy in breast cancer

... microarray. The unprecedented ability to monitor the expression of entire genomes has led to biological discoveries that would not have been possible by other ...inability to ... Voir le document complet

145

Revisiting the cutaneous impact of oral hormone replacement therapy.

Revisiting the cutaneous impact of oral hormone replacement therapy.

... All the current reports indicate that chronologic aging, climacteric estrogen deficiency, and adequate hormone therapy exert profound effects on various parts of the skin... Introduction[r] ... Voir le document complet

9

Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.

Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.

... for breast cancer and 95% confidence intervals (CIs) were estimated using Cox proportional hazards regression models with age as the ...risks of breast cancer associated with ... Voir le document complet

13

Plasma metabolomic signatures associated with long-term breast cancer risk in the SU.VI.MAX prospective cohort

Plasma metabolomic signatures associated with long-term breast cancer risk in the SU.VI.MAX prospective cohort

... for the following baseline characteristics: age (continuous), BMI (continuous), smoking status (current, former, and nonsmokers), height (continuous), alcohol intake (continuous), physical activity (low, moderate, ... Voir le document complet

9

No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study.

No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study.

... as the time scale and adjusted for years of education (≤12, 13-16, ≥15), height (as continuous variable), body mass index category (as a time- dependent variable according to the height at ... Voir le document complet

6

Show all 10000 documents...